- JP-listed companies
- TMS Co., Ltd
- Cash flow
TMS Co., Ltd【JP:4891】Cash flow
Market cap
¥6.2B
P/E ratio
Timbs Inc. develops anti-inflammatory drugs from black mold compounds, targeting diseases like stroke and inflammatory conditions through partnerships with major pharmaceutical companies.
| 2021/02 | 2022/02 | 2023/02 | 2024/02 | 2025/02 | 2025/12 | |
| Depreciation & amortization | 4 | 1 | 7 | 7 | 4 | 0 |
| Cash from operations | -738 | 1,262 | -688 | -823 | -494 | -780 |
| Capital expenditures | -0 | -4 | -13 | -3 | -31 | -3 |
| Cash from investing | -0 | -17 | -14 | -3 | -31 | -3 |
| Cash from financing | 1,101 | 246 | 1,689 | 688 | 1 | 641 |
| Free cash flow | ||||||
| FCF margin (%) | - | - | - | - | - |